These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9365064

  • 1. Growth impairment and growth hormone therapy in children treated for malignant brain tumours.
    Ilveskoski I, Saarinen UM, Wiklund T, Sipilä I, Mäkipernaa A, Perkkiö M, Lanning M, Salmi TT, Pihko H.
    Eur J Pediatr; 1997 Oct; 156(10):764-9. PubMed ID: 9365064
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours.
    Spoudeas HA, Charmandari E, Brook CG.
    Med Pediatr Oncol; 2003 Apr; 40(4):224-9. PubMed ID: 12555249
    [Abstract] [Full Text] [Related]

  • 3. Growth response to growth hormone therapy following craniospinal irradiation.
    Clayton PE, Shalet SM, Price DA.
    Eur J Pediatr; 1988 Aug; 147(6):597-601. PubMed ID: 3181200
    [Abstract] [Full Text] [Related]

  • 4. Short- and long-term (final height) data in children with normal variant short stature treated with growth hormone.
    Schmitt K, Blümel P, Waldhör T, Lassi M, Tulzer G, Frisch H.
    Eur J Pediatr; 1997 Sep; 156(9):680-3. PubMed ID: 9296529
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone therapy in children after cranial/craniospinal radiation therapy: sexually dimorphic outcomes.
    Lerner SE, Huang GJ, McMahon D, Sklar CA, Oberfield SE.
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6100-4. PubMed ID: 15579765
    [Abstract] [Full Text] [Related]

  • 6. Growth and puberty after growth hormone treatment after irradiation for brain tumours.
    Ogilvy-Stuart AL, Shalet SM.
    Arch Dis Child; 1995 Aug; 73(2):141-6. PubMed ID: 7574858
    [Abstract] [Full Text] [Related]

  • 7. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone.
    Giorgiani G, Bozzola M, Locatelli F, Picco P, Zecca M, Cisternino M, Dallorso S, Bonetti F, Dini G, Borrone C.
    Blood; 1995 Jul 15; 86(2):825-31. PubMed ID: 7606014
    [Abstract] [Full Text] [Related]

  • 8. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL, Stirling HF, Kelnar CJ, Savage MO, Dunger DB, Buckler JM, Shalet SM.
    Clin Endocrinol (Oxf); 1997 May 15; 46(5):571-8. PubMed ID: 9231053
    [Abstract] [Full Text] [Related]

  • 9. Effects of low-dose cranial radiation on growth hormone secretory dynamics and hypothalamic-pituitary function.
    Costin G.
    Am J Dis Child; 1988 Aug 15; 142(8):847-52. PubMed ID: 3164978
    [Abstract] [Full Text] [Related]

  • 10. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J.
    Clin Endocrinol (Oxf); 2003 May 15; 58(5):647-52. PubMed ID: 12699449
    [Abstract] [Full Text] [Related]

  • 11. Growth failure after treatment of pediatric brain tumors.
    Clarson CL, Del Maestro RF.
    Pediatrics; 1999 Mar 15; 103(3):E37. PubMed ID: 10049993
    [Abstract] [Full Text] [Related]

  • 12. Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.
    Beckers D, Thomas M, Jamart J, Francois I, Maes M, Lebrethon MC, De Waele K, Tenoutasse S, De Schepper J.
    Eur J Endocrinol; 2010 Mar 15; 162(3):483-90. PubMed ID: 19969557
    [Abstract] [Full Text] [Related]

  • 13. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours.
    Gleeson HK, Shalet SM.
    Endocr Relat Cancer; 2004 Dec 15; 11(4):589-602. PubMed ID: 15613441
    [Abstract] [Full Text] [Related]

  • 14. Final height and weight of long-term survivors of childhood malignancies.
    Müller HL, Klinkhammer-Schalke M, Kühl J.
    Exp Clin Endocrinol Diabetes; 1998 Dec 15; 106(2):135-9. PubMed ID: 9628245
    [Abstract] [Full Text] [Related]

  • 15. Growth response to growth hormone therapy following cranial irradiation.
    Clayton PE, Shalet SM, Price DA.
    Eur J Pediatr; 1988 Aug 15; 147(6):593-6. PubMed ID: 3181199
    [Abstract] [Full Text] [Related]

  • 16. Endocrine disorders following treatment of childhood brain tumours.
    Livesey EA, Hindmarsh PC, Brook CG, Whitton AC, Bloom HJ, Tobias JS, Godlee JN, Britton J.
    Br J Cancer; 1990 Apr 15; 61(4):622-5. PubMed ID: 2109998
    [Abstract] [Full Text] [Related]

  • 17. Thyroid function after treatment of brain tumors in children.
    Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR.
    J Pediatr; 1991 Nov 15; 119(5):733-7. PubMed ID: 1941379
    [Abstract] [Full Text] [Related]

  • 18. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor.
    Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Lange M, Poulsen HS, Müller J.
    J Clin Endocrinol Metab; 2003 Jul 15; 88(7):3149-54. PubMed ID: 12843158
    [Abstract] [Full Text] [Related]

  • 19. Final height in growth hormone-deficient childhood cancer survivors after growth hormone therapy.
    Rodari G, Cattoni A, Albanese A.
    J Endocrinol Invest; 2020 Feb 15; 43(2):209-217. PubMed ID: 31452114
    [Abstract] [Full Text] [Related]

  • 20. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
    Hovi L, Saarinen-Pihkala UM, Vettenranta K, Lipsanen M, Tapanainen P.
    Bone Marrow Transplant; 1999 Nov 15; 24(10):1131-6. PubMed ID: 10578163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.